SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-23-000175
Filing Date
2023-10-05
Accepted
2023-10-05 19:05:28
Documents
4
Period of Report
2023-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1696547117.html 3  
1 FORM 3 wk-form3_1696547117.xml 3 2207
2 EX-24 nfowler_poa.htm EX-24 871
3 nfowler_poa001.jpg GRAPHIC 183975
4 nfowler_poa002.jpg GRAPHIC 84274
  Complete submission text file 0001367644-23-000175.txt   374082
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EMERGENT BIOSOLUTIONS INC. 400 PROFESSIONAL DR. STE. 400 GAITHERSBURG MD 20879
Business Address
Fowler Neal Franklin (Reporting) CIK: 0001493692 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 231312392